Current Ratio of Quince Therapeutics, Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Quince Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • Quince Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 294%, a 61% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Quince Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 294% -454% -61% 30 Sep 2025
Q2 2025 585% -342% -37% 30 Jun 2025
Q1 2025 615% -747% -55% 31 Mar 2025
Q4 2024 699% -1336% -66% 31 Dec 2024
Q3 2024 748% -2717% -78% 30 Sep 2024
Q2 2024 927% -1925% -67% 30 Jun 2024
Q1 2024 1362% -886% -39% 31 Mar 2024
Q4 2023 2034% +397% +24% 31 Dec 2023
Q3 2023 3465% +2300% +197% 30 Sep 2023
Q2 2023 2852% +1883% +194% 30 Jun 2023
Q1 2023 2248% +1429% +175% 31 Mar 2023
Q4 2022 1638% +840% +105% 31 Dec 2022
Q3 2022 1165% +361% +45% 30 Sep 2022
Q2 2022 969% +158% +19% 30 Jun 2022
Q1 2022 818% -78% -8.7% 31 Mar 2022
Q4 2021 798% -200% -20% 31 Dec 2021
Q3 2021 804% -289% -26% 30 Sep 2021
Q2 2021 812% -505% -38% 30 Jun 2021
Q1 2021 896% -619% -41% 31 Mar 2021
Q4 2020 998% -644% -39% 31 Dec 2020
Q3 2020 1093% -1026% -48% 30 Sep 2020
Q2 2020 1317% 30 Jun 2020
Q1 2020 1515% 31 Mar 2020
Q4 2019 1642% 31 Dec 2019
Q3 2019 2118% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.